Results 21 to 30 of about 3,956 (171)

Treatment of ophthalmopathy in the course of Graves’ disease

Journal of Education, Health and Sport, 2019
: Introduction: Graves’ disease is an autoimmune disease in which the TSH receptor (TSHR) is an autoantigen. Its stimulation by antibodies inhibiting thyrotropin binding causes increased secretion of free thyroid hormones and consequently symptoms of ...
Magdalena Woźniak, Ewa Tywanek, Grzegorz Rudzki, Joanna Świrska, Agnieszka Zwolak, Robert Jan Łuczyk   +5 more
doaj   +3 more sources

Clinical scoring scales in thyroidology: A compendium

Indian Journal of Endocrinology and Metabolism, 2011
This compendium brings together traditional as well as contemporary scoring and grading systems used for the screening and diagnosis of various thyroid diseases, dysfunctions, and complications. The article discusses scores used to help diagnose hypo-and
Sanjay Kalra, Sachin K Khandelwal, Aakshit Goyal   +2 more
doaj   +1 more source

Nanotechnology Lighting the Way for Gene Therapy in Ophthalmopathy: From Opportunities toward Applications

Molecules, 2023
Hereditary ophthalmopathy is a well-described threat to human visual health affecting millions of people. Gene therapy for ophthalmopathy has received widespread attention with the increasing understanding of pathogenic genes. Effective and safe delivery
Weiming Ren, Suyang Duan, Chao Dai, Chunbao Xie, Lingxi Jiang, Yi Shi   +5 more
doaj   +1 more source

Teprotumumab for Thyroid-Associated Ophthalmopathy [PDF]

, 2017
BACKGROUND: Thyroid-associated ophthalmopathy, a condition commonly associated with Graves’ disease, remains inadequately treated. Current medical therapies, which primarily consist of glucocorticoids, have limited efficacy and present safety concerns ...
Kahaly, GJ, Harris, GJ, Gabriel, K, Ezra, DG, Fleming, JC, Hink, EM, Goldberg, RA, Salvi, M, Douglas, RS, Smith, TJ, Dailey, RA, Antonelli, A, Gigantelli, JW, Shriver, EM, Woodward, RM, Tang, RA, Magni, G, Couch, SM, Hayek, BR   +18 more
core   +4 more sources

Ophthalmopathy Consciousness Level in Graves Patients: Graves Ophthalmopathy

Erciyes Tıp Dergisi/Erciyes Medical Journal, 2014
Objective: We aimed to examine the knowledge and consciousness levels of participators about Graves orbitopathy (GO) by conducting an investigation of ophthalmopathy consciousness of Graves patients, providing coordination among all health insti- tutions and ophthalmologists and giving information about the subject to patients. Materials and Methods: A
Kan E.K., Kan E., Ecemiş G.C., Bahadır Ç.T., Çolak R.   +4 more
openaire   +2 more sources

Autophagy in graves’ ophthalmopathy

Frontiers in Cell and Developmental Biology, 2023
Graves’ ophthalmopathy (GO) is an inflammatory autoimmune disease that affects the eyes. It can significantly alter the quality of life in patients because of its distinctive pathological appearance and the effect on vision. To date, the exact pathological mechanism of GO has not been explicitly discovered.
Yu-Qing Chen, Lian-Di Gao, Yi-Lin Liu, Ya Shen, Jia-Le Diao, Wei-Hua Yang, Rui-Li Wei   +6 more
openaire   +3 more sources

Maukirana grahonmada – Psychiatric manifestations of Graves' hyperthyroidism and ophthalmopathy?

Medical Journal of Dr. D.Y. Patil Vidyapeeth, 2018
Bhuta vidya (Ayurvedic psychiatry) is one of the eight specialties of Ayurveda. It deals with various psychiatric conditions caused by the affliction of evil spirits.
Prasad Mamidi, Kshama Gupta
doaj   +1 more source

The Efficiacy of High Dose Pulse Steroid (Methylprednisolone) Therapy in Graves Ophthalmopathy

Endocrinology Research and Practice, 2022
Thyroid ophthalmopathy is the most common cause of bilateral or unilateral proptosis in adults. Since the recognition of autoimmune mechanisms in the pathogenesis of Graves' ophthalmopathy, a number of investigators have reported on the use of various ...
Bilgin Özmen, Esin Erkin, Murat Saruç
doaj   +2 more sources

Diagnostic Options in Graves' or Non‐Graves' Thyrotoxicosis: A Review for Clinical Practice

Clinical Endocrinology, EarlyView.
ABSTRACT Objective Distinguishing Graves' disease (GD) from the other causes of thyrotoxicosis is essential for appropriate management. The clinical phenotype of GD has evolved over time and is currently more heterogenous and milder than in the past. Consequently, the differential diagnosis of thyrotoxicosis is often challenging.
Lorenzo Scappaticcio, Pierpaolo Trimboli, Paola Caruso, Chiara Porcellini, Daniela Forestiere, Maria Ida Maiorino, Katherine Esposito, Giuseppe Bellastella   +7 more
wiley   +1 more source

Leukemic ophthalmopathy in children [PDF]

Cancer, 1976
Abnormalities of the eye were detected in 52 of 657 children (9%) suffering from acute leukemia. The treatment for leukemia was single agent chemotherapy administered sequentially. "Prophylactic" treatment of the central nervous system was not administered.
E W, Ridgway, N, Jaffe, D S, Walton
openaire   +2 more sources